SOCRA CCRP Cheat Sheet 2026

The 30 highest-yield SOCRA CCRP facts, distilled from real exam questions. Print it, save it as a PDF, or study it here — free, no sign-up.

1. How long must essential clinical trial documents typically be retained after the formal discontinuation of a drug's clinical development? → At least 2 years
2. According to ICH-GCP, how often should a monitor visit a clinical trial site? → With a frequency determined by the monitoring plan based on trial characteristics
3. What is the purpose of a certificate of analysis (CoA) for the investigational product? → To certify that the product batch meets predetermined quality specifications
4. Who is primarily responsible for maintaining investigational product accountability records at a clinical trial site? → The principal investigator or designee
5. Under 21 CFR 312.32, what is the reporting timeframe for serious, unexpected AEs that are NOT fatal or life-threatening? → 15 calendar days
6. In the context of CDISC standards, what does CDASH stand for? → Clinical Data Acquisition Standards Harmonization
7. What is the key distinction between a 'sponsor' and an 'investigator' under FDA regulations? → The sponsor initiates and oversees the trial; the investigator conducts it at the site
8. Which of the following is an example of an input port commonly found on modern monitors? → HDMI
9. Which ICH guideline defines Good Clinical Practice (GCP) standards internationally? → ICH E6
10. Under FDA regulations, what is the timeframe for expedited reporting of an unexpected fatal or life-threatening SAE to the FDA? → 7 calendar days
11. What is a source document in the context of clinical trial documentation? → An original document, data, or record where clinical findings are first recorded
12. Which section of the Investigator's Brochure (IB) contains information about the known and potential risks of the investigational product? → Summary of Data and Guidance for the Investigator
13. What is 'unmasking' or 'unblinding' in the context of SAE reporting? → Revealing the subject's treatment assignment to assess causality for an SAE
14. A participant in a clinical trial is hospitalized for a condition the investigator believes is related to the study drug. What should the investigator do first? → Report the SAE to the sponsor immediately or per the protocol timeline
15. A temperature excursion is detected in the IP storage refrigerator over a weekend. What is the appropriate FIRST action? → Quarantine the affected IP and notify the sponsor
16. What does the term "resolution" refer to in a monitor? → The number of pixels displayed on the screen
17. What is a 'Sponsor-Investigator' in clinical research? → An individual who both initiates and conducts a clinical investigation
18. In a double-blind, randomized controlled trial, who typically holds the randomization code to protect blinding integrity? → An unblinded third party such as the sponsor's statistician or an unblinded pharmacist
19. What document is used at a clinical trial site to track all dispensing, administration, and returns of investigational product? → Investigational Product Accountability Log
20. Which of the following is a key characteristic of good documentation? → Clear, concise, and accurate
21. What is 'research misconduct' in the context of clinical trials? → Fabrication, falsification, or plagiarism in conducting or reporting research
22. Which section of the Code of Federal Regulations addresses IRB composition and review procedures? → 21 CFR Part 56
23. Under FDA regulations, how long must an investigator retain clinical trial records after the investigation is discontinued or completed? → 3 years
24. Under 21 CFR Part 50, which individuals are considered 'vulnerable' populations requiring additional protections? → Pregnant women, prisoners, and children
25. In a randomized controlled trial (RCT) study protocol, what is the purpose of randomization? → To minimize selection bias and ensure comparability between groups
26. Which of the following patients is unable to give informed consent? → A child without parental guidance
27. Under GCP, what is required for a research site to conduct a clinical trial? → Adequate facilities, qualified staff, IRB approval, and signed agreements with the sponsor
28. Which document must be signed before a sponsor can ship investigational product to a clinical trial site? → Clinical Trial Agreement (CTA) and regulatory approval
29. Why is it important to predefine the statistical analysis plan in the study protocol? → To ensure the analysis is transparent and free from bias
30. Which regulatory body must approve a new drug's IND before Phase 1 clinical trials can begin in the US? → FDA